{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T23:08:26Z","timestamp":1788736106874,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003191","name":"R\u00e9gion Normandie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"National Centre for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015519","name":"University of Caen Normandy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ctrv.2026.103198","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T18:49:25Z","timestamp":1785696565000},"page":"103198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies"],"prefix":"10.1016","volume":"149","author":[{"given":"Elsa","family":"Sarrazin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Valable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie A.","family":"P\u00e9r\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Colloc'h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lesueur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Bernaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Aury-Landas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ctrv.2026.103198_bb0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2026.103198_bb0010","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/neuonc\/now182","article-title":"Tumor treating fields: a novel treatment modality and its use in brain tumors","volume":"18","author":"Hottinger","year":"2016","journal-title":"Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.ctrv.2026.103198_bb0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/nop\/npac070","article-title":"The predictive value of partial MGMT promoter methylation for IDH-wild-type glioblastoma patients","volume":"10","author":"Torre","year":"2022","journal-title":"Neuro-Oncol Pract"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103198_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082019","article-title":"Impact of hypoxia on carbon ion therapy in glioblastoma cells: modulation by LET and hypoxia-dependent genes","volume":"12","author":"Valable","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103198_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111845","article-title":"ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma","volume":"388","author":"Persson","year":"2020","journal-title":"Exp Cell Res"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103198_bb0030","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41419-020-03150-0","article-title":"The HIF1\u03b1\/HIF2\u03b1-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12935-025-03823-w","article-title":"HIF-1\u03b1 and HIF-2\u03b1: synergistic regulation of glioblastoma malignant progression during hypoxia and apparent chemosensitization in response to hyperbaric oxygen","volume":"25","author":"Wang","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-025-07617-w","article-title":"Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1\u03b1\/HIF2\u03b1 regulation","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ctrv.2026.103198_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40478-021-01124-7","article-title":"Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration","volume":"9","author":"Uneda","year":"2021","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"7015","key":"10.1016\/j.ctrv.2026.103198_bb0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2026.103198_bb0060","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1038\/s41598-019-46014-0","article-title":"Targeting of replicating CD133 and OCT4\/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure","volume":"9","author":"Guerra-Rebollo","year":"2019","journal-title":"Sci Rep"},{"issue":"7120","key":"10.1016\/j.ctrv.2026.103198_bb0065","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103198_bb0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/02688697.2021.1907306","article-title":"The prognosis of glioblastoma: a large, multifactorial study","volume":"35","author":"Luo","year":"2021","journal-title":"Br J Neurosurg"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103198_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087047","article-title":"Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets","volume":"24","author":"Erices","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"Supplement_4","key":"10.1016\/j.ctrv.2026.103198_bb0080","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1093\/noajnl\/vdae204","article-title":"The glioma microenvironment and its impact on antitumor immunity","volume":"7","author":"Hansen","year":"2025","journal-title":"Neuro-Oncol Adv"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103198_bb0085","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through Neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103198_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051126","article-title":"Slow-cycling cells in glioblastoma: a specific population in the cellular mosaic of cancer stem cells","volume":"14","author":"Yang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ctrv.2026.103198_bb0100","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1038\/s41467-024-51117-y","article-title":"Metabolic and transcriptomic reprogramming during contact inhibition-induced quiescence is mediated by YAP-dependent and YAP-independent mechanisms","volume":"15","author":"Kang","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0105","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-022-32448-0","article-title":"A slow-cycling\/quiescent cells subpopulation is involved in glioma invasiveness","volume":"13","author":"Antonica","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ctrv.2026.103198_bb0110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1593\/neo.13662","article-title":"Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma","volume":"15","author":"Richichi","year":"2013","journal-title":"Neoplasia N Y N"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103198_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051126","article-title":"Slow-cycling cells in glioblastoma: a specific population in the cellular mosaic of cancer stem cells","volume":"14","author":"Yang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"192","key":"10.1016\/j.ctrv.2026.103198_bb0120","doi-asserted-by":"crossref","first-page":"166","DOI":"10.24976\/Discov.Med.202537192.14","article-title":"Glioblastoma stem cells: MAP17 as a novel predictive biomarker and therapeutic target associated with quiescence and immune evasion","volume":"37","author":"Aghamiri","year":"2025","journal-title":"Discov Med"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030059","article-title":"Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia","volume":"7","author":"Hofstetter","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103198_bb0130","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1172\/JCI96393","article-title":"TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence","volume":"128","author":"Puig","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ctrv.2026.103198_bb0135","doi-asserted-by":"crossref","unstructured":"Cho J, Min HY, Pei H, et al. The ATF6-EGF pathway mediates the awakening of slow-cycling chemoresistant cells and tumor recurrence by stimulating tumor angiogenesis. Cancers (Basel) 2020;12(7):7. doi:https:\/\/doi.org\/10.3390\/cancers12071772.","DOI":"10.3390\/cancers12071772"},{"issue":"23","key":"10.1016\/j.ctrv.2026.103198_bb0140","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798772","article-title":"Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma","volume":"37","author":"Hoang-Minh","year":"2018","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2026.103198_bb0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-030-22254-3_15","article-title":"Tumor dormancy and slow-cycling Cancer cells","volume":"1164","author":"Davis","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0150","first-page":"1","article-title":"The adaptive transition of glioblastoma stem cells and its implications on treatments","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.ctrv.2026.103198_bb0155","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2019.01.076","article-title":"Phenotypic plasticity of invasive edge glioma stem-like cells in response to ionizing radiation","volume":"26","author":"Minata","year":"2019","journal-title":"Cell Rep"},{"issue":"9\u201310","key":"10.1016\/j.ctrv.2026.103198_bb0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1101\/gad.321968.118","article-title":"Wnt and notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells","volume":"33","author":"Rajakulendran","year":"2019","journal-title":"Genes Dev"},{"issue":"14","key":"10.1016\/j.ctrv.2026.103198_bb0165","doi-asserted-by":"crossref","first-page":"11882","DOI":"10.18632\/oncotarget.3592","article-title":"Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"issue":"35","key":"10.1016\/j.ctrv.2026.103198_bb0170","doi-asserted-by":"crossref","first-page":"59282","DOI":"10.18632\/oncotarget.19546","article-title":"PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype","volume":"8","author":"Guadagno","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2026.103198_bb0175","doi-asserted-by":"crossref","unstructured":"Zhu Y, Yang P, Wang Q, et al. The effect of CXCR4 silencing on epithelial-mesenchymal transition related genes in glioma U87 cells. Anat Rec Hoboken NJ 2007. 2013;296(12):1850\u20131856. doi:https:\/\/doi.org\/10.1002\/ar.22821.","DOI":"10.1002\/ar.22821"},{"issue":"21","key":"10.1016\/j.ctrv.2026.103198_bb0180","doi-asserted-by":"crossref","first-page":"8644","DOI":"10.1073\/pnas.1221478110","article-title":"Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3","volume":"110","author":"Mao","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103198_bb0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/neuonc\/nox142","article-title":"Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization","volume":"20","author":"Garnier","year":"2018","journal-title":"Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.ctrv.2026.103198_bb0190","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.celrep.2019.07.002","article-title":"Glutamine Synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair","volume":"28","author":"Fu","year":"2019","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103198_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13123055","article-title":"Dual role of integrin Alpha-6 in glioblastoma: supporting stemness in proneural stem-like cells while inducing radioresistance in mesenchymal stem-like cells","volume":"13","author":"Stanzani","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103198_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094871","article-title":"Prevalence and Clinicopathologic characteristics of the molecular subtypes in malignant glioma: a multi-institutional analysis of 941 cases","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103198_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijms20112746","article-title":"Proneural-mesenchymal transition: phenotypic plasticity to acquire multitherapy resistance in glioblastoma","volume":"20","author":"Fedele","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103198_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091216","article-title":"Molecular subtypes of glioblastoma are relevant to lower grade glioma","volume":"9","author":"Guan","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103198_bb0220","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1093\/neuonc\/noaf160","article-title":"Proneural-mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import","volume":"27","author":"Bourmeau","year":"2025","journal-title":"Neuro-Oncol."},{"issue":"16","key":"10.1016\/j.ctrv.2026.103198_bb0225","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1073\/pnas.1525349113","article-title":"Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages","volume":"113","author":"Peterson","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"10.1016\/j.ctrv.2026.103198_bb0230","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1038\/onc.2014.257","article-title":"VEGF drives cancer-initiating stem cells through VEGFR-2\/Stat3 signaling to upregulate Myc and Sox2","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-015-0420-3","article-title":"Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF","volume":"14","author":"Fessler","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ctrv.2026.103198_bb0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40478-025-02031-x","article-title":"Endothelial transdifferentiation of glioma stem cells: a literature review","volume":"13","author":"Buruiana","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ctrv.2026.103198_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12929-020-00632-3","article-title":"Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-\u03b2 signaling","volume":"27","author":"Lin","year":"2020","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0250","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/bjc.2017.157","article-title":"CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells","volume":"117","author":"Maciaczyk","year":"2017","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s10020-021-00383-3","article-title":"Macrophages and cancer stem cells: a malevolent alliance","volume":"27","author":"Allavena","year":"2021","journal-title":"Mol Med"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103198_bb0260","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1113\/expphysiol.2006.033506","article-title":"Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia","volume":"91","author":"Guzy","year":"2006","journal-title":"Exp Physiol"},{"issue":"25","key":"10.1016\/j.ctrv.2026.103198_bb0265","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.RA118.003647","article-title":"Control of mitochondrial superoxide production by reverse electron transport at complex I","volume":"293","author":"Robb","year":"2018","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103198_bb0270","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1158\/1078-0432.CCR-21-4283","article-title":"Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post-hoc analysis of the EORTC randomized phase 3 CATNON trial","volume":"28","author":"Tesileanu","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103198_bb0275","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctrv.2026.103198_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41368-020-00087-0","article-title":"Radiotherapy targeting cancer stem cells \u201cawakens\u201d them to induce tumour relapse and metastasis in oral cancer","volume":"12","author":"Liu","year":"2020","journal-title":"Int J Oral Sci"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103198_bb0285","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.celrep.2016.11.056","article-title":"Clonal variation in drug and radiation response among glioma-initiating cells is linked to proneural-mesenchymal transition","volume":"17","author":"Segerman","year":"2016","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103198_bb0290","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10555-012-9394-4","article-title":"The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies","volume":"31","author":"Fokas","year":"2012","journal-title":"Cancer Metastasis Rev"},{"issue":"20","key":"10.1016\/j.ctrv.2026.103198_bb0295","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","article-title":"The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a Cancer stem cell phenotype","volume":"8","author":"Heddleston","year":"2009","journal-title":"Cell Cycle Georget Tex"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103198_bb0300","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3892\/ol.2016.4113","article-title":"Epithelial-mesenchymal transition in glioblastoma progression","volume":"11","author":"Iwadate","year":"2016","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103198_bb0305","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.freeradbiomed.2011.11.024","article-title":"ERK\/GSK3\u00df\/snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition","volume":"52","author":"Nagarajan","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0310","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1631\/jzus.B2200269","article-title":"Hypoxia-induced ROS aggravate tumor progression through HIF-1\u03b1-SERPINE1 signaling in glioblastoma","volume":"24","author":"Zhang","year":"2023","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.ctrv.2026.103198_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156111","article-title":"Molecular drivers of epithelial-mesenchymal transition (EMT) in glioblastoma and impact on therapy resistance","volume":"272","author":"Tian","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103198_bb0320","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41419-019-2055-6","article-title":"Ionizing radiation induces endothelial transdifferentiation of glioblastoma stem-like cells through the Tie2 signaling pathway","volume":"10","author":"Deshors","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ctrv.2026.103198_bb0325","series-title":"Handbook of oxidative stress in Cancer: Mechanistic aspects","first-page":"137","article-title":"The implication of ROS homeostasis in the modulation of EMT signaling and its role in manipulating tumor microenvironment","author":"Chakraborty","year":"2022"},{"issue":"37","key":"10.1016\/j.ctrv.2026.103198_bb0330","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1038\/onc.2016.261","article-title":"A novel interaction of PAK4 with PPAR\u03b3 to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma","volume":"36","author":"Kesanakurti","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103198_bb0335","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2016.03.027","article-title":"Olig2-dependent reciprocal shift in PDGF and EGF receptor signaling regulates tumor phenotype and mitotic growth in malignant glioma","volume":"29","author":"Lu","year":"2016","journal-title":"Cancer Cell"},{"issue":"20","key":"10.1016\/j.ctrv.2026.103198_bb0340","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/0008-5472.CAN-14-3331","article-title":"STAT3 blockade inhibits a radiation-induced proneural-to-mesenchymal transition in glioma","volume":"75","author":"Lau","year":"2015","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103198_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.509","article-title":"Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance","volume":"5","author":"Dahan","year":"2014","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.ctrv.2026.103198_bb0350","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/cdd.2014.31","article-title":"Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy","volume":"21","author":"Auffinger","year":"2014","journal-title":"Cell Death Differ"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103198_bb0355","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1158\/1535-7163.MCT-15-0675","article-title":"Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model","volume":"15","author":"Lee","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/jca.54402","article-title":"HIF1\u03b1\/HIF2\u03b1 induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions","volume":"13","author":"Wang","year":"2022","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103198_bb0365","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ijrobp.2010.12.070","article-title":"Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results","volume":"82","author":"Ogawa","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103198_bb0370","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1021\/acsami.4c20383","article-title":"Injectable biocompatible zeolite nanocrystals for enhanced tumor oxygenation and MRI imaging","volume":"17","author":"Amedlous","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103198_bb0375","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctrv.2026.103198_bb0380","doi-asserted-by":"crossref","first-page":"15195","DOI":"10.1038\/s41598-020-72290-2","article-title":"Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor","volume":"10","author":"Renfrow","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0385","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00018-025-05642-8","article-title":"Targeting HIF-2\u03b1 in glioblastoma reshapes the immune infiltrate and enhances response to immune checkpoint blockade","volume":"82","author":"Espinoza","year":"2025","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0390","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11060-023-04456-7","article-title":"Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma","volume":"165","author":"Strowd","year":"2023","journal-title":"J Neuro-Oncol"},{"issue":"16","key":"10.1016\/j.ctrv.2026.103198_bb0395","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s40265-021-01606-x","article-title":"Belzutifan: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0400","doi-asserted-by":"crossref","first-page":"18742","DOI":"10.1038\/s41598-020-75300-5","article-title":"The HIF1\u03b1\/JMY pathway promotes glioblastoma stem-like cell invasiveness after irradiation","volume":"10","author":"Gauthier","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103198_bb0405","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/1535-7163.MCT-11-0480","article-title":"Therapeutic potential of AZD1480 for the treatment of human glioblastoma","volume":"10","author":"McFarland","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0410","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12868-025-00956-6","article-title":"Shikonin inhibits epithelial-mesenchymal transition in glioblastoma cells by upregulating p53 and promoting miR-361-5p level to suppress ZEB1 expression","volume":"26","author":"Zhang","year":"2025","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0415","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2321770","article-title":"RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT\/GSK3-\u03b2 pathway","volume":"25","author":"Sun","year":"2024","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103198_bb0420","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.7150\/jca.50631","article-title":"Inhibition of Cathepsin S restores TGF-\u03b2-induced epithelial-to-mesenchymal transition and tight junction turnover in glioblastoma cells","volume":"12","author":"Wei","year":"2021","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02257-0","article-title":"When dormancy fuels tumour relapse","volume":"4","author":"Santos-de-Frutos","year":"2021","journal-title":"Commun Biol"},{"issue":"1\u20132","key":"10.1016\/j.ctrv.2026.103198_bb0430","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11010-010-0525-3","article-title":"Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance","volume":"344","author":"Lei","year":"2010","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"10.1016\/j.ctrv.2026.103198_bb0435","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/annonc\/mdt249","article-title":"A phase I\/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer","volume":"24","author":"Kelly","year":"2013","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103198_bb0440","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2415557122","article-title":"Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation","volume":"122","author":"He","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103198_bb0445","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.18632\/oncotarget.2937","article-title":"Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe","volume":"6","author":"P\u00e9r\u00e8s","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103198_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091580","article-title":"Particle therapy to overcome cancer radiation resistance: \u201cARCHADE\u201d consortium updates in radiation biology","volume":"17","author":"Valable","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0455","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1038\/s41598-018-22022-4","article-title":"Radiosensitization effect of Talazoparib, a Parp inhibitor, on glioblastoma stem cells exposed to low and high linear energy transfer radiation","volume":"8","author":"Lesueur","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103198_bb0460","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/neuonc\/noab040","article-title":"A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma","volume":"23","author":"Brown","year":"2021","journal-title":"Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0465","article-title":"Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment","volume":"3","author":"Al Feghali","year":"2021","journal-title":"Neuro-oncol Adv"},{"key":"10.1016\/j.ctrv.2026.103198_bb0470","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40880-019-0351-2","article-title":"Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I\/III clinical trial","volume":"39","author":"Kong","year":"2019","journal-title":"Cancer Commun"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0475","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2011.06.2004","article-title":"Carbon ion irradiation inhibits glioma cell migration through downregulation of integrin expression","volume":"83","author":"Rieken","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103198_bb0480","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123837","article-title":"Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche","volume":"4","author":"Chiblak","year":"2019","journal-title":"JCI Insight"},{"issue":"21","key":"10.1016\/j.ctrv.2026.103198_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213354","article-title":"Carbon ion irradiation downregulates notch signaling in glioma cell lines, impacting cell migration and spheroid formation","volume":"11","author":"Kumar","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103198_bb0490","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijrobp.2015.06.015","article-title":"Radiosensitivity of patient-derived glioma stem cell 3-dimensional cultures to photon, proton, and carbon irradiation","volume":"95","author":"Chiblak","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030573722600112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030573722600112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:29:11Z","timestamp":1788733751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030573722600112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":97,"alternative-id":["S030573722600112X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103198","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103198"}}